Verastem Expected To Rock Upcoming Conferences

Verastem to Present at Upcoming Conferences CAMBRIDGE, MA – June 10 — Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will participate at several upcoming conferences. The presentation details are as follows: 2014 Wells Fargo Healthcare Conference on Tuesday, June 17, 2014 at 3:30 p.m. ET at The InterContinental Hotel in Boston, MA ROTH Healthcare Corporate Access Day on Tuesday, June 24, 2014 at the Dorchester Hotel in London, UK 9th Annual JMP Securities Healthcare Conference on Wednesday June 25, 2014 at 1:30 p.m. ET at the Westin New York Grand Central in New York, NY Webcasts of the Wells Fargo and JMP Securities presentations can be accessed by visiting the investors section of the Company’s website at Replays will be archived on the Verastem website for 90 day s following the presentation dates.

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt. For more information, please visit Forward-looking statements: Any statements in this press release about future expectations, plans and prospects for the Company constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements. The Company anticipates that subsequent events and developments will cause the Company’s views to change. Ho wever, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. Verastem, Inc. Brian Sullivan, 617-252-9314

This entry was posted in News. Bookmark the permalink.